Sarepta Therapeutics Stock Price (NASDAQ:SRPT)

Add to My Stocks
$42.44 $0.1 (0.24%) SRPT stock closing price Jul 26, 2017 (Closing)
Prev Close* : $42.54
Market Cap:
$2.66B
Day Low: $42.24
52 Week Low: $23.28
Open: $43.01
Volume: 3488984
Day High: $44.08
52 Week High: $63.73
Dividend:
N/A

Latest Stock Market News

Latest Articles

Sarepta Therapeutics News - From Partners

SRPT Stockcharts

View SRPT PE ratio, PS ratio stocks charts and compare with peers.
SRPT Chart
Note: Compare Sarepta Therapeutics stock price history with the index and industry peers.

Sarepta Therapeutics Valuation

PS ratio (
price to sales ratio
)
41.1

Sarepta Therapeutics Financial Ratios

Asset Turnover
0.14
Debt to Equity
0.03

SRPT Industry Peers

Company Price Change (%)
Kythera Biopharma (KYTH)74.980 (0%)
Dbv Tech (DBVT)43.90.07 (0.16%)
Aviragen Therapeutics (AVIR)0.570.01 (1.79%)
Biocryst Pharma (BCRX)5.030.01 (0.2%)
Gilead Sciences (GILD)74.190.45 (0.61%)
Ptc Therapeutics (PTCT)20.840.31 (1.47%)
Vertex Pharma (VRTX)163.421.45 (0.9%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)39.652.32 (6.21%)
Dynavax Technologies (DVAX)10.40.5 (5.05%)
MannKind (MNKD)1.320.06 (4.76%)
BioDelivery Sciences (BDSI)3.50.15 (4.48%)
Biogen Inc (BIIB)295.6112.65 (4.47%)
Paratek Pharma (PRTK)21.450.85 (4.13%)
Vital Therapies (VTL)2.750.1 (3.77%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017
CompanyPriceChange (%)
Integra LifeSciences (IART)49.745.88 (10.57%)
Idera Pharma (IDRA)1.940.12 (5.83%)
Kamada (KMDA)5.150.25 (4.63%)
Peregrine Pharma (PPHM)4.30.2 (4.44%)
Fate Therapeutics (FATE)2.830.11 (3.74%)
Compugen (CGEN)3.90.15 (3.7%)
Trevena (TRVN)2.720.1 (3.55%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017

Sarepta Therapeutics Inc Stock News - Partner Headlines

Sarepta Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues5.42M1.25M9.75M14.21M37.32M
Net Income-267.26M-220.03M-135.78M-111.98M-121.28M
Total Operating Expense272.01M221.43M143.54M104.49M67.03M
view Sarepta Therapeutics Inc income statement
balance sheet20162015201420132012
Total Assets424.1M273.78M295.03M291.56M204.99M
Total Liabilities87.41M83.43M47.38M44.37M81.31M
Shareholders Equity336.69M190.34M247.65M247.19M123.67M
view Sarepta Therapeutics Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-15.76M31.98M-22.13M12.26M-5.3M
Net Cash From (Used By) Operating Activities-245.82M-149.46M-128.53M-64.69M-29.69M
Increase (Decrease) In Prop Plant And Equipment-5.34M-3.4M-25.44M-2.37M-0.1M
view Sarepta Therapeutics Inc cashflow statement

Sarepta Therapeutics Stock Message Board

As of last trading day, Sarepta Therapeutics stock price was 42.44. Looking at Sarepta Therapeutics market capitalization, which currently stands at 2.66B, we can say that SRPT stock is a Mid cap stock. Sarepta Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy SRPT stock than sell it, then Sarepta Therapeutics stock price goes up. Conversely, if more investors wanted to sell SRPT stock than buy it, there would be greater supply than demand, and the stock price would fall. 3488984 SRPT shares were traded yesterday, and Sarepta Therapeutics stock chart shows that the SRPT stock quote hit a day high of 44.08 and day low of 42.24. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. One can observe stock price trends and check for volatility by checking Sarepta Therapeutics stock price history.